Show an ad over header. AMP

I am the FIRST

Johnson & Johnson takes "full responsibility" of COVID vaccine output at Baltimore plant

Johnson & Johnson announced late Saturday that it's "assuming full responsibility" for manufacturing its COVID-19 vaccine at a Baltimore plant where 15 million doses were ruined last week.

Of note: AstraZeneca said Saturday night it is in "full cooperation with the U.S. government" to move production from the facility, run by Emergent BioSolutions, which been producing both vaccines.

Why it matters: The Biden administration took the "extraordinary" step of intervening as officials were "worried" the error would "erode public confidence in the vaccines," notes the New York Times, which first reported the news Saturday.

Driving the news: J&J said in a statement that it's "adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the company specialists already at Emergent."

  • Bloomberg reports that J&J is conducting the operation "with help from the Biden administration."
  • AstraZeneca said in a statement Saturday night it "will work with the U.S. Government to identify an alternative location."

For the record: The plant has yet to receive authorization from the Food and Drug Administration for either vaccine and the error is unlikely to impact the U.S. government's accelerating vaccine rollout.

  • President Biden is stepping up plans to enable every American adult can be eligible to receive a dose by May, but the mix-up underscores how manufacturing issues "could complicate the rollout," per Bloomberg.

What to watch: J&J said in its statement it "expects to deliver nearly 100 million single-shot doses of its COVID-19 vaccine to the U.S. Government by the end of May."

What they're saying: Emergent spokesperson Nina DeLorenzo told the Washington Post Saturday that the company had been told of AstraZeneca's relocation plans and would stop manufacturing the vaccine in "the next few days."

  • "We are welcoming additional Johnson & Johnson personnel on-site at Bayview for their technical expertise and support," DeLorenzo added.
  • Representatives for Emergent and the Department of Health and Human Services did not immediately respond to Axios' request for comment.

regular 4 post ff

infinite scroll 4 pff

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories